Table of Contents

A massive wastage of the global resources.
Placenta as a source of stem cells and as a key organ for fetomaternal tolerance.
Placenta and umbilical cord in traditional Chinese medicine.
Use of umbilical venous blood on assessing the biochemical variations of acid-base, nutritional and metabolic parameters on growth-retarded fetuses, in comparison with gestational control cases: a study.
Umbilical cord blood transfusion and its therapeutic potentialities.
Autologous placental blood transfusion for the therapy of anemic neonates.
Cord blood: a massive waste of a life-saving resource: a perspective on its current and potential uses.
Clinical experience of cord blood autologous transfusion.
Emergency use of human cord blood.
Hemoglobin-based oxygen carriers in trauma care: the US multicenter prehospital trial.
Placental umbilical cord blood as a true blood substitute with an edge.
Implications of feto-maternal cell transfer in normal pregnancy.
Early reports on the prognostic implications and immunotherapeutic potentials of Cd34 rich cord whole blood transfusion in advanced breast cancer with severe anemia.
Anti-inflammatory effects of human cord blood and its potential implications in neurological disorders.
Transforming "waste" into gold: identification of novel stem cells resources with therapeutic potential in neuromuscular disorders.
Human umbilical cord blood cells for stroke.
Placental umbilical cord blood transfusion for stem cell therapy in neurological diseases.
Umbilical cord and its blood: a perspective on its current and potential use in ophthalmology.
Umbilical vein grafts for lower limb revascularization.
Cord blood stem cells in angiogenesis. Endothelial progenitor cells from cord blood: magic bullets against ischemia?.
Therapeutic potential of placental umbilical cord blood in cardiology.
Stem cell therapy for heart failure using cord blood.
Human umbilical cord blood mononuclear cells in the treatment of acute myocardial infarction.
Umbilical cord-derived mesenchymal stem cells.
Cord blood stem cell expansion ex vivo: current status and future strategies.
Embryonic-like stem cells and the importance of human umbilical cord blood for regenerative medicine.
Use of non-hematopoietic stem cells of fetal origin from cord blood, umbilical cord, and placenta in regeneration medicine.
Animal studies of cord blood and regeneration.
Immune privilege of cord blood.
Combination cellular therapy for regenerative medicine: the stem cell niche.
Use of cord blood in regenerative medicine.
Comparisons between related and unrelated cord blood collection and/or banking for transplantation or research: the UK NHS blood and transplant experience.
Donor and collection-related variables affecting product quality in ex utero cord blood banking.
Cord blood as a source of hematopoietic progenitors for transplantation.
Amniotic fluid and placenta stem cells.
Use of amniotic membrane, amniotic fluid, and placental dressing in advanced burn patients.
Clinical use of amniotic fluid in osteoarthritis: a source of cell therapy.
A study and follow-up (1999-2009) of human fetal neuronal tissue transplants at a heterotopic site outside the brain in cases of advanced idiopathic Parkinsonism.
Ethical issues surrounding umbilical cord blood donation and banking. The proposed book is a holistic review of the clinical use of placental substances, amniotic fluid, the umbilical cord and its contents. It is intended to be a unique presentation of the current advances as well as also discussing the future applications of these substances. Attention is yet to be focused on the widespread clinical use of pregnancy-related biological substances. The aim for this book is to inform clinicians of the use of such materials and increase awareness of their therapeutic benefits. As such, this reference resource will be of great value to hematologists, rheumatologists.